NEW YORK (GenomeWeb News) – Protea Biosciences and Gelcompany, a wholly owned subsidiary of Australian firm Fluorotechnics, today said that they will collaborate on developing new technology for improved protein analysis.

Under the agreement, Protea has the right to distribute certain Gelcompany products in the North American life sciences market. The companies also said that they intend to collaborate on the co-development of new protein separation products for the global life sciences market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.